Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.
暂无分享,去创建一个
S. Scherer | L. Tsui | R. Hegele | A. Boright | P. Connelly | P. Connelly | J. Brunt | L. Tsui
[1] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[2] S. Scherer,et al. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.
[3] S. Scherer,et al. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes , 1997, The Lancet.
[4] P. Connelly,et al. Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration , 1997 .
[5] M. Odawara,et al. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.
[6] D. Sanghera,et al. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[7] B. Zinman,et al. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] B. L. Du,et al. Structural and functional diversity of paraoxonases , 1996, Nature Medicine.
[9] D. Arveiler,et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study. , 1996, Atherosclerosis.
[10] M. Jauhiainen,et al. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. , 1996, The Journal of clinical investigation.
[11] B. La Du,et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.
[12] R. Hegele,et al. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins , 1996, Current opinion in lipidology.
[13] R. Hegele,et al. Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. , 1996, Hypertension.
[14] A. Marian,et al. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. , 1995, The Journal of clinical investigation.
[15] G. Charpentier,et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes , 1995, The Lancet.
[16] R. Hegele,et al. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. , 1995, Circulation.
[17] R. Hegele,et al. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[18] R. Hegele,et al. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. , 1994, Circulation.
[19] J. Witte,et al. Genetic dissection of complex traits. , 1994, Nature genetics.
[20] R. Hegele,et al. A gene-gender interaction affecting plasma lipoproteins in a genetic isolate. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] E. Reiner,et al. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. , 1993, Chemico-biological interactions.
[22] M. Blatter,et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. , 1993, European journal of biochemistry.
[23] J. Little,et al. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[24] S. Ratnam,et al. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins , 1991, Clinical genetics.
[25] P. Winocour,et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. , 1991, Atherosclerosis.
[26] R. Hegele. The genetic basis of atherosclerosis , 1997, International journal of clinical & laboratory research.
[27] R. Hegele. Candidate genes, small effects, and the prediction of atherosclerosis. , 1997, Critical reviews in clinical laboratory sciences.
[28] N. Schork. Genetically complex cardiovascular traits. Origins, problems, and potential solutions. , 1997, Hypertension.
[29] R. Hegele,et al. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. , 1995, Arteriosclerosis, thrombosis, and vascular biology.